Shire proposes $30 bln all-share tie-up with Baxalta
August 04, 2015 at 07:47 AM EDT
LONDON, Aug 4 (Reuters) - London-listed pharmaceutical group Shire said it was seeking to buy U.S. firm Baxalta in a $30 billion all-share deal to create a global specialist in medicines treating rare diseases with sales of $20 billion by 2020.
